Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-06

Clinical Trial Update: Anticholinergic vs. Botox Comparison Study [Phase 3]

View source ↗

Summary

Phase 3 study comparing an anticholinergic therapy to Botox for urge urinary incontinence and overactive bladder has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anticholinergic agent (urinary incontinence) (anticholinergic)
  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: NICHD Pelvic Floor Disorders Network | Conditions: Urge Urinary Incontinence, Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2017-12-06